Skip to content

Clinical trials

Hepatitis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: Taiwan Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20072
20093
20111
20121
20132
20141
20151
20161
20213
20223
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
National Taiwan University Hospital3
GlaxoSmithKline2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
Novartis Pharmaceuticals2
Sinew Pharma Inc.2
Arbutus Biopharma Corporation1
AusperBio Therapeutics Inc.1
F-star Therapeutics, Inc.1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis23
Hepatitis B, Chronic10
Hepatitis B9
Hepatitis, Chronic5
Liver Diseases3
DNA Virus Infections2
Digestive System Diseases2
Hepatitis C, Chronic2
Hepatitis, Viral, Human2
Liver Failure, Acute2

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.